2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

TScan Therapeutics Inc. is the latest Massachusetts biotech to trim its workforce as it funnels cash resources toward its ...

The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.

Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Portfolio manager Eden Rahim sees biotech entering a new bull market amid lower rates, better trial data and renewed investor ...

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in October 2025.

Former NFL quarterback Tom Brady said on Tuesday that his dog, Junie, is a clone of his late pet, Lua, who passed away two ...